-
1دورية أكاديمية
المؤلفون: Lorenzo Belluomini, Francesco Fiorica, Antonio Frassoldati
المصدر: Oncology and Therapy, Vol 7, Iss 1, Pp 83-91 (2019)
مصطلحات موضوعية: Combination treatment, Immune system, Immunotherapy, NSCLC, Radiotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://link.springer.com/article/10.1007/s40487-019-0092-zTest; https://doaj.org/toc/2366-1070Test; https://doaj.org/toc/2366-1089Test
-
2
المؤلفون: Francesco Fiorica, Lorenzo Belluomini, Antonio Frassoldati
المصدر: Oncology and Therapy
Oncology and Therapy, Vol 7, Iss 1, Pp 83-91 (2019)مصطلحات موضوعية: Durvalumab, Immune Checkpoint Inhibitors, Radiotherapy, NSCLC, Combination treatment, Immune system, Immunotherapy, Radiotherapy, business.industry, medicine.medical_treatment, Immune checkpoint inhibitors, Pembrolizumab, Immunotherapy, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, NSCLC, lcsh:RC254-282, NO, Radiation therapy, Immune system, Oncology, Atezolizumab, Combination treatment, Cancer research, Commentary, Medicine, Nivolumab, business, Immune Checkpoint Inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664876920fd5f15a640d861692170c41Test
http://europepmc.org/articles/PMC7360008Test -
3دورية
المصدر: Oncology and Therapy; June 2019, Vol. 7 Issue: 1 p83-91, 9p